Skip to main content
TipRanks
Go Ultimate75% OFF

Jeff Fairman Insider Profile

11 Followers

Jeff Fairman, VP, Research at Vaxcyte, holds 354.05K shares in Vaxcyte (Ticker: PCVX).

Jeff Fairman's Trading History

PCVX
Vaxcyte
Oct 28, 2022VP, ResearchUninformative Sell400.00K$22.44M
PCVX
Insider Shares: 354.05K (0.45%)

Jeff Fairman has not reported any informative transactions for PCVX, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 28, 2022Uninformative Sell$400.00K10,000$40.00―
Oct 13, 2022Uninformative Sell$127.50K5,000$25.50―
Sep 07, 2022Uninformative Sell$132.85K5,000$26.57―
Sep 07, 2022Uninformative Sell$13.69K519$26.38―
Aug 05, 2022Uninformative Sell$383.50K15,000$25.56―

You May Also Like

Jeff Fairman insider profile FAQ

What stocks does Jeff Fairman hold?
Jeff Fairman holds: PCVX stocks.
What was Jeff Fairman’s latest transaction?
Jeff Fairman’s latest transaction was an Uninformative Sell of $400.00K.
What is Jeff Fairman's role in Vaxcyte?
Jeff Fairman's role in Vaxcyte is VP, Research.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.